Issue 3/2005
Content (13 Articles)
Control of Atm−/− thymic lymphoma cell proliferation in vitro and in vivo by dexamethasone
Xianghong Kuang, Mingshan Yan, Na Liu, Virginia L. Scofield, Wenan Qiang, Jodi Cahill, Williams S. Lynn, Paul K. Y. Wong
Incorporation of OSI-7836 into DNA of Calu-6 and H460 xenograft tumors
Frank Richardson, Chris Black, Katherine Richardson, April Franks, Edward Wells, Susan Karimi, Gina Sennello, Karen Hart, Denny Meyer, David Emerson, Eric Brown, Jeremy LeRay, Christy Nilsson, Blake Tomkinson, Raymond Bendele
Uptake of the anthracycline pirarubicin into mouse M5076 ovarian sarcoma cells via a sodium-dependent nucleoside transport system
Katsuhito Nagai, Kazuki Nagasawa, Sadaki Fujimoto
Magnesium and potassium homeostasis during cisplatin treatment
H. Lajer, M. Kristensen, H. H. Hansen, S. Christensen, Ten Jonassen, G. Daugaard
Population pharmacokinetic analysis of 17-(allylamino)-17-demethoxygeldanamycin (17AAG) in adult patients with advanced malignancies
Xueyu Chen, Robert R. Bies, Ramesh K. Ramanathan, Eleanor G. Zuhowski, Donald L. Trump, Merrill J. Egorin
Particular cutaneous side effects with etoposide-containing courses: is VP16 or etoposide phosphate responsible?
Katel Marigny, Fabienne Aubin, Gwenola Burgot, Edouard Le Gall, Virginie Gandemer
Apoptosis of murine melanoma B16-BL6 cells induced by quercetin targeting mitochondria, inhibiting expression of PKC-α and translocating PKC-δ
Xian-Ming Zhang, Jia Chen, Yu-Gui Xia, Qiang Xu
Phase I study of an oral formulation of irinotecan administered daily for 14 days every 3 weeks in patients with advanced solid tumours
Nadja E. Schoemaker, I. E. L. M. Kuppens, Wim W. Ten Bokkel Huinink, Patricia Lefebvre, Jos H. Beijnen, Sylvie Assadourian, Ger-Jan Sanderink, Jan H. M. Schellens
Weekly cisplatin paclitaxel and continuous infusion fluorouracil in patients with recurrent and/or metastatic head and neck squamous cell carcinoma: a phase II study
M. Schena, C. Barone, N. Birocco, D. Dongiovanni, G. Numico, I. Colantonio, O. Bertetto
Description of paclitaxel resistance-associated genes in ovarian and breast cancer cell lines
Zhenfeng Duan, Diana E. Lamendola, Yifei Duan, Rushdia Z. Yusuf, Michael V. Seiden
DNA damage, c-myc suppression and apoptosis induced by the novel topoisomerase II inhibitor, salvicine, in human breast cancer MCF-7 cells
Hua-Rui Lu, Ling-Hua Meng, Min Huang, Hong Zhu, Ze-Hong Miao, Jian Ding
A phase IB clinical and pharmacokinetic study of the angiogenesis inhibitor SU5416 and paclitaxel in recurrent or metastatic carcinoma of the head and neck
Matthew M. Cooney, Kou-Yi Tserng, Vinit Makar, R. Jeff McPeak, Stephen T. Ingalls, Afshin Dowlati, Beth Overmoyer, Keith McCrae, Pamela Ksenich, Pierre Lavertu, Percy Ivy, Charles L. Hoppel, Scot Remick
Oxaliplatin activity in head and neck cancer cell lines
Magali Espinosa, Moises Martinez, José Luis Aguilar, Aída Mota, Jaime G. De la Garza, Vilma Maldonado, Jorge Meléndez-Zajgla